Skip to Content


In the US, Remicade (infliximab systemic) is a member of the following drug classes: antirheumatics, TNF alfa inhibitors and is used to treat Ankylosing Spondylitis, Behcet's Disease, Bullous Pemphigoid, Celiac Disease, Cogan's Syndrome, Crohn's Disease, Crohn's Disease - Acute, Crohn's Disease - Maintenance, Giant Cell Arteritis, Inflammatory Bowel Disease, Juvenile Idiopathic Arthritis, Kawasaki Disease, Neurosarcoidosis, Pemphigoid, Pemphigus, Plaque Psoriasis, Polychondritis, Psoriasis, Psoriatic Arthritis, Pulmonary Fibrosis, Pyoderma Gangrenosum, Rheumatoid Arthritis, SAPHO Syndrome, Sarcoidosis, Sjogren's Syndrome, Spondyloarthritis, Subcorneal Pustular Dermatosis, Toxic Epidermal Necrolysis, Ulcerative Colitis and Uveitis.

US matches:

UK matches:

Ingredient matches for Remicade


Infliximab is reported as an ingredient of Remicade in the following countries:

  • Argentina
  • Austria
  • Belgium
  • Bosnia & Herzegowina
  • Canada
  • Chile
  • China
  • Colombia
  • Czech Republic
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Greece
  • Hong Kong
  • Hungary
  • Iceland
  • Indonesia
  • Ireland
  • Israel
  • Italy
  • Japan
  • Latvia
  • Lebanon
  • Lithuania
  • Malaysia
  • Mexico
  • Netherlands
  • New Zealand
  • Norway
  • Oman
  • Peru
  • Poland
  • Portugal
  • Romania
  • Russian Federation
  • Serbia
  • Singapore
  • Slovakia
  • Spain
  • Sweden
  • Switzerland
  • Thailand
  • Tunisia
  • Turkey
  • United Kingdom
  • United States
  • Vietnam

← International Drug Name Search

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.